MedTrace Logo

Risk Stratification of Nodal PTCL

NCT03040206 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 405

Last updated 2019-08-07

No results posted yet for this study

Summary

This study is to investigate the prognostic significance of enhanced International Prognostic Index (NCCN-IPI) and post-treatment PET results in patients with newly diagnosed nodal peripheral T-cell lymphoma (PTCL), and establish a risk stratification model for nodal PTCL patients.

Conditions

  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Angioimmunoblastic T-cell Lymphoma
  • Anaplastic Large Cell Lymphoma, ALK-negative

Sponsors & Collaborators

  • Chonnam National University Hospital

    collaborator OTHER

  • Kyungpook National University Hospital

    collaborator OTHER

  • Keimyung University Dongsan Medical Center

    collaborator OTHER

  • Korea University Anam Hospital

    collaborator OTHER

  • Korea University Guro Hospital

    collaborator OTHER

  • Dong-A University Hospital

    collaborator OTHER

  • Pusan National University Hospital

    collaborator OTHER

  • Yeungnam University Hospital

    collaborator OTHER

  • Inje University

    collaborator OTHER

  • Chungnam National University Hospital

    collaborator OTHER

  • Samsung Medical Center

    collaborator OTHER

  • Chonbuk National University Hospital

    lead OTHER

Principal Investigators

  • Ho-Young Yhim · Chonbuk National University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03040206 on ClinicalTrials.gov